Physician profile
William A Davis
NPI 1194757567
$790.52
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $388 · 2023: $16.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $156.27 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $118.03 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.64 | 2019-2020 | |
| Amarin Pharma, INC. | $72.88 | 2019-2020 | |
| Forte Bio-Pharma LLC | $66.84 | 2020 | |
| Pfizer INC. | $59.77 | 2019-2020 | |
| Amgen INC. | $58.97 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $38.03 | 2019 | |
| Kaleo, INC. | $34.56 | 2019 | |
| Boston Scientific Corporation | $16.09 | 2023 | Rezum Generator |
| Novo Nordisk INC | $12.57 | 2020 | |
| Ironwood Pharmaceuticals, INC | $12.56 | 2020 | |
| Eisai INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.